Japan’s PAFSC Approves New Lymphocytic Leukemia Drug, Adds Gastritis To H. Pylori Eradication
This article was originally published in PharmAsia News
Executive Summary
The Health Ministry’s Pharmaceutical Affairs and Food Sanitation Council Second Committee on Drugs discussed and approved the authorization GSK’s Arzerra (recombinant ofatumumab) for the treatment of chronic lymphocytic leukemia